Daiwa Securities Group Inc. Rani Therapeutics Holdings, Inc. Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
42Shares Held
5.93MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.58 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$986,6600.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$686,0811.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$623,4030.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$420,8120.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $34M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...